211
Participants
Start Date
April 30, 2006
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
AV Therapy Assessment-B301 investigational device
Atrial and ventricular tachyarrhythmia therapy delivered by the B301 investigational device
Alaska Heart Institute, Anchorage
Northern California Heart Care, Larkspur
Orlando Regional Hospital, Orlando
Heart and Vascular Institute, St. Petersburg
Piedmont Hospital, Atlanta
St. Joseph Hospital, Savannah
Good Samaritan Hospital, Downers Grove
Heart Care Research Foundation, Merrionette Park
St. Mary Medical Center, Hobart
Mercy Hospital Medical Center, Des Moines
Central Baptist Hospital, Lexington
Louisville Cardiology Medical Group, Louisville
Medical Center Cardiologist Research, Louisville
Owensboro Mercy Health System, Owensboro
Ochsner Foundation Hospital, New Orleans
Boston Medical Center, Boston
Lahey Clinic Medical Center, Burlington
Baystate Medical Center, Springfield
University of Massachusetts, Worcester
Henry Ford Hospital, Detroit
Saint Mary's Duluth Clinic, Duluth
St. Anthony's Medical Center, St Louis
Sunrise Hospital & Medical Center, Las Vegas
Deborah Heart and Lung Center, Browns Mills
Mount Sinai Medical Center, New York
Christ Hospital - Cincinnati, Cincinnati
The Cleveland Clinic Foundation, Cleveland
Ohio State University Medical Center, Columbus
Hillcrest Medical Center, Tulsa
Abington Memorial Hospital, Abington
Reading Hospital and Medical Center, West Reading
Baylor University Medical Center, Dallas
Center For Cardiac Arrhythmias, Houston
Inova Fairfax Hospital, Fairfax
Sentara Norfolk General Hospital, Norfolk
Chippenham Medical Center, Richmond
Lead Sponsor
Boston Scientific Corporation
INDUSTRY